TLR2/4 pathway has been reported to influence chronic inflammation in tumors, activates dendritic cell traffic and its associated tumor-specific, cytotoxic T-cell responses in the TIME21, and reduces tumor progression through multiple mechanisms22,23. This evidence concerns the gene TLR2 and neoplasm.